U.S. federal trademark · Serial No. 98559594
Providing healthcare information regarding the treatment of cancer, immunological, inflammatory and neurological disorders; Providing healthcare information regarding drugs for the treatment of cancer, immunological, inflammatory and neurological disorders
Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific reagent antibodies for medical diagnosis purposes
Printed educational and informational publications related to cancer, immunological, inflammatory and neurological disorders, namely, pamphlets, newsletters, guides
Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific therapeutic antibodies for scientific and medical research
Providing prescription drug research information relating to drugs for the diagnosis and treatment of cancer, immunological, inflammatory and neurological disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.